CV Sciences (CVSI) Receivables (2013 - 2026)
CV Sciences (CVSI) posted Receivables of $391000.0 for Q1 2026, down 2.74% sequentially from $402000.0 in Q4 2025, and down 9.07% YoY from $430000.0 in Q1 2025.
CV Sciences (CVSI) Receivables (2013 - 2026) Analysis & Trends
CV Sciences has reported Receivables for 14 years, with the latest figure at $391000.0 in Q1 2026.
- Quarterly Receivables fell 9.07% year-over-year to $391000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $391000.0 (down 9.07% YoY) and the FY2025 annual result came in at $402000.0, down 22.99% from the prior year.
- Receivables slipped to $391000.0 in Q1 2026 per CVSI's latest filing, from $402000.0 in the prior quarter.
- Over five years, Receivables peaked at $7.4 million in Q2 2022 and troughed at $391000.0 in Q1 2026.
- A 5-year average of $2.5 million and a median of $545000.0 in 2025 frame the typical range for Receivables.
- The sharpest annual moves came in 2022 and 2023: Receivables surged 206.11% in 2022, then slumped 93.99% in 2023.
- Over 5 years, Receivables stood at $7.2 million in 2022, then plunged by 93.99% to $431000.0 in 2023, then grew by 21.11% to $522000.0 in 2024, then decreased by 22.99% to $402000.0 in 2025, then declined by 2.74% to $391000.0 in 2026.
- According to Business Quant data, Receivables over the past three periods registered $391000.0, $402000.0, and $405000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.08 Bn |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 348,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 348,000.00 |
| Mar 31, 2026 | 391,000.00 |
| Dec 31, 2025 | 402,000.00 |
| Sep 30, 2025 | 405,000.00 |
| Jun 30, 2025 | 545,000.00 |
| Mar 31, 2025 | 430,000.00 |
| Dec 31, 2024 | 522,000.00 |
| Sep 30, 2024 | 422,000.00 |
| Jun 30, 2024 | 639,000.00 |
| Mar 31, 2024 | 507,000.00 |
| Dec 31, 2023 | 431,000.00 |
| Sep 30, 2023 | 666,000.00 |
| Jun 30, 2023 | 611,000.00 |
| Mar 31, 2023 | 7.06 Mn |
| Dec 31, 2022 | 7.17 Mn |
| Sep 30, 2022 | 7.10 Mn |
| Jun 30, 2022 | 7.35 Mn |
| Mar 31, 2022 | 7.33 Mn |
| Dec 31, 2021 | 2.34 Mn |
| Sep 30, 2021 | 8.16 Mn |